fashion -WSS

fashion

author：focus 2025-09-30 22:55:04 - browse：4673

Paul Berggreen, a gastroenterologist at Arizona Digestive Health who formed a new lobbying group for independent physician practices. Arizona Digestive Health/ GI Alliance

Private equity gets a bad rap in health care. But some doctors see that kind of cash and consolidation as the only way for their practices to survive — and now, they’re taking that message to Washington.

Lower pay, difficult negotiations with insurance companies, regulatory requirements from both government and commercial payers, expensive and inefficient IT systems, and the challenge of competing against hospital systems have created a “cascade of problems that seem like they are almost insurmountable” for independent practices, said Paul Berggreen, a gastroenterologist at Arizona Digestive Health.

Berggreen is joining with other doctors to start a lobbying group for private practices, the brand-new American Independent Medical Practice Association, or AIMPA, to fight against those problems and advocate for private practice physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Let's speed up science by embracing open access publishing

leisure time

WSS

Medicare Advantage isn’t working — for anyone

Medicare Advantage isn’t working — for anyone

Are embryos people? Reproductive medicine's future depends on the answer

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

NEJM study measures Covid brain fog, impact on IQ

ASCO: Palliative care found as helpful given virtually as in person

Wikipedia

fashion

knowledge

Medicare details structure of new drug price negotiation program

Ohio train derailment: Experts on toxic chemical risks

Affirmative action in medical school literally saved lives

At ASCO, AstraZeneca reports strong data for breast cancer drug

BioMarin wins approval for gene therapy to treat hemophilia A

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Trump demands the U.S. pay no more for drugs than other countries … again

NIH documents show early flaws of $1.6 billion long Covid program

Sports medicine is finally prioritizing gender equality

Are embryos people? Reproductive medicine's future depends on the answer

knowledge

Ohio train derailment: Experts on toxic chemical risks

Let's speed up science by embracing open access publishing

Study fuels hope CAR

Ionis drug prevents swelling attacks due to hereditary angioedema

Pfizer is about to make a big push in cancer. Will investors listen?

With trial win, GSK could get blood cancer drug back on market

focus

focus

leisure time

hotspot